Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Birner

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Cancer|July 10, 2001
Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesisP Birner, B Gatterbauer, G Oberhuber, et al.
Histology and Histopathology|September 2, 2005
DEC1 expression in 1p-aberrant oligodendroglial neoplasmsM Preusser, P Birner, I M Ambros, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
DNA topoisomerase IIalpha expression in optic pathway gliomas of childhoodM Bredel, I Slavc, P Birner, et al.
Acta Neuropathologica|August 4, 2001
Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseasesT Voigtländer, S Klöppel, P Birner, et al.
Annals of Neurology|November 18, 2000
Alteration of the serotonergic nervous system in fatal familial insomniaJ Wanschitz, S Klöppel, C Jarius, et al.
Neuropathology and Applied Neurobiology|November 16, 2004
Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survivalM Preusser, T Ströbel, P Birner, et al.
International Journal of Oncology|November 20, 2001
Prognostic relevance of three histological grading methods in breast cancerL Latinovic, G Heinze, P Birner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancerS F Schoppmann, D Tamandl, L Roberts, et al.
Cancer Biology & Therapy|December 19, 2017
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysisA Ilhan-Mutlu, H Taghizadeh, A Beer, et al.
Seminars in Thrombosis and Hemostasis|May 18, 1999
Dimensions of quality of life and self-monitoring therapy with oral anticoagulants--still research or everyday practice?T Wenzel, S Mörsdorf, I Sibitz, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cancer|July 10, 2001
Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesisP Birner, B Gatterbauer, G Oberhuber, et al.
Histology and Histopathology|September 2, 2005
DEC1 expression in 1p-aberrant oligodendroglial neoplasmsM Preusser, P Birner, I M Ambros, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
DNA topoisomerase IIalpha expression in optic pathway gliomas of childhoodM Bredel, I Slavc, P Birner, et al.
Acta Neuropathologica|August 4, 2001
Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseasesT Voigtländer, S Klöppel, P Birner, et al.
Annals of Neurology|November 18, 2000
Alteration of the serotonergic nervous system in fatal familial insomniaJ Wanschitz, S Klöppel, C Jarius, et al.
Neuropathology and Applied Neurobiology|November 16, 2004
Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survivalM Preusser, T Ströbel, P Birner, et al.
International Journal of Oncology|November 20, 2001
Prognostic relevance of three histological grading methods in breast cancerL Latinovic, G Heinze, P Birner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancerS F Schoppmann, D Tamandl, L Roberts, et al.
Cancer Biology & Therapy|December 19, 2017
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysisA Ilhan-Mutlu, H Taghizadeh, A Beer, et al.
Seminars in Thrombosis and Hemostasis|May 18, 1999
Dimensions of quality of life and self-monitoring therapy with oral anticoagulants--still research or everyday practice?T Wenzel, S Mörsdorf, I Sibitz, et al.
Pageof 6